It is encouraging that a new paradigm, creating new hypotheses, is emerging about breast cancer-a 'regulation-based' model'.
One hypothesis might be that self-regulation contributes to this process. Meanwhile, could Professor Baum provide me with a bridge over a hole which his article has created in my mind. If he is confident that the extent of local therapy does not influence survival, why is it necessary for breast cancer surgery to he confined to specialists performing many operations a year? No quackery here, I hope. Lancet 1996; 348:1149-51 agree with some of Michael Baum' s arguments, hut several of his statements and assumptions must he challenged. I would query whether a concentration on claims of 'holism' is a fruitful line of attack: as Professor Baum would agree, all good medicine is holistic. A truer source of divergence is the complementary focus on the host milieu rather than the external pathogen, leading to an emphasis on ways of mobilizing the innate self-healing powers of the body. Conventional commentators, unfamiliar with the world of unorthodox therapies and firmly schooled in an aggressive approach to the disease process, usually overlook this fundamental difference.
J L T Birley
But the core of Baum's argument relates to evidence. He is right about the slender hody of hard evidence supporting most complementary therapies, especially in relation to cancer treatment. The reasons for this are not all to do with reluctance to test a hypothesis. Chronic lack of funding, of any sort of research culture with attendant infrastructure and expertise, and of the kind of street credibility that opens doors to grant-giving bodies and mainstream journals are among the historical obstacles to progress in this area. Where he is entirely wrong is in his assumption that unproven equates to disproved. How does he know that a complementary treatment offers a 'false promise of a cure' until it is fully tested, or that patients recovered in ancient times 'despite' their treatment? This view can only be a product of Baum' s own belief system.
I understand how Professor Baum finds it
galling to be accused of having a closed mind. What many of us in complementary medicine find galling is to see the moral high ground seized by scientists who, despite having received countless billions in public and charitable funding have made pitifully small inroads into the overall cancer mortality figures! while denigrating those outside the charmed circle who came at the problem from a different angle. As I said in a short parliamentary debate in 1994 2 , one is left wondering 'what other profession could show such calm assurance in the face of so many years of conspicuous failure, and still retain the respect of government and the public".
It is ironic that, with his recent interest in regulatory approaches to canccrl, Michael Baum is moving closer than he knows to complementary territory. 
Earl Baldwin of Bewdley

Epidural anaesthesia and urinary dysfunction
The quality of the paper by Williams and colleagues on epidural anaesthesia and urinary dysfunction after total hip replace-ment (December 1995 JRSM, pp 699P-701P) seems to have suffered considerably from the lack of an anaesthetic collaborator or reviewer. As 'all the attending anaesthetists were unaware of the study' and provided no input, vital data such as the volume of local anaesthetic agent used and the frequency of injection were not mentioned. Furthermore the choice of 0.5% bupivacaine (not 'bupivocaine'. as mis-spelt throughout the article) for post-operative pain relief was totally inappropriate, as this is a high, motor-blocking concentration of the agent. The use of dilute epidural solutions of local anaesthetic, opioid or clonidinel, alone or in combination, is usually associated with good post-operative pain relief and a low incidence of urinary retention in this situation. Anaesth 1992; 68:339--43 Dr Williams replies below:
It was not our intention, as surgeons, to precipitate discussion of relative merits of various epidural anaesthetic techniques but merely to report our experiences. Our study revealed a significant increase in postoperative urinary retention in men who had received supplementary epidural anaesthesia. In view of the well established rise in the risk of deep sepsis in association with the need for postoperative urethral catheterization we believe our findings were worthy of notice.
The epidural drug regimens were as follows. Peroperatively 0.5% bupivacaine was used as stated in our paper. Postoperatively for analgesia 0.1% bupivacaine and 10 flg/mL fentanyl was used, the rate of infusion being titrated to the patients' analgesia requirements (usually 5-8 mLlh) with occasional bolus doses of 0.25% bupivacaine.
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